Stay updated on Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.

Latest updates to the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, reflecting a minor update to the page's version history. This change does not modify content or functionality.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a small update to the page’s version metadata.SummaryDifference0.0%

- Check39 days agoChange DetectedThe study page now includes new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note 'No longer looking for participants'. In addition, there is a formatting change from 'Intervention / Treatment' to 'Intervention/Treatment' and a site revision marker 'Revision: v3.6.0'.SummaryDifference0.4%

- Check46 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This denotes a small, behind-the-scenes update or patch to the page's documentation.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a minor editorial/documentation update. This change does not modify the core study details and appears to be a routine version bump.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page’s footer has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a website release/version change rather than a change to the clinical trial study details.SummaryDifference0.0%

Stay in the know with updates to Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.